Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeladon Pharma. Regulatory News (CEL)

Share Price Information for Celadon Pharma. (CEL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 85.50
Bid: 85.00
Ask: 86.00
Change: -9.00 (-9.47%)
Spread: 1.00 (1.176%)
Open: 95.00
High: 95.00
Low: 86.00
Prev. Close: 95.00
CEL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

7 Oct 2009 09:56

RNS Number : 3740A
Celsis International PLC
07 October 2009
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

CELSIS INTERNATIONAL PLC

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

 

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

ACCEPTANCE OF OFFER BY NASTOR INVESTMENTS LIMITED

 X

3. Full name of person(s) subject to the notification obligation:

 LLOYDS BANKING GROUP PLC

4. Full name of shareholder(s) (if different from 3.):

 SEE SECTION 9

5. Date of the transaction and date on which the threshold is crossed or reached:

 2 OCTOBER 2009

6. Date on which issuer notified:

 6 OCTOBER 2009

7. Threshold(s) that is/are crossed or reached:

DIRECT/INDIRECT DECREASE TO BELOW 3%

  

8. Notified details:

A: Voting rights attached to shares

Class/type of shares

if possible using the ISIN CODE

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of Shares

Number of Voting Rights

Number of shares

Number of voting rights

% of voting rights

Direct

Direct

Indirect

Direct

Indirect

ORD 5P SHARES 

 1,237,057

 1,237,057

 NIL

 NIL

 1,127

 NIL

 0.005%

GB00B0CDF69

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ Conversion Period

Number of voting rights that may be acquired if the instrument is exercised/ converted.

% of voting rights

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Exercise price

Expiration date

Exercise/ Conversion period

Number of voting rights instrument refers to

% of voting rights

 

 

 

 

 

Nominal

Delta

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

 1,127

 0.005%

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:

 N/A

Proxy Voting:

10. Name of the proxy holder:

 N/A

11. Number of voting rights proxy holder will cease to hold:

 N/A

12. Date on which proxy holder will cease to hold voting rights:

 N/A

13. Additional information:

 NOTIFICATION USING THE TOTAL VOTING RIGHTS FIGURE OF 22,983,369

14. Contact name:

 KENNY MELVILLE

15. Contact telephone number:

 0131 243 5301

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUBSWRKBRRRRA
Date   Source Headline
23rd May 20247:00 amRNSSupply of Products to New US Customer
15th May 20242:45 pmRNSExercise of Share Options and Total Voting Rights
14th May 20247:00 amRNSFinal Results
10th May 20247:00 amRNSFundraise, RCF Extension, Termination of CLN & TVR
7th Mar 20247:00 amRNSEarly Economic Analysis of Feasibility Study Data
14th Dec 20237:00 amRNSProduct Supplied to First Two Sales Contracts
12th Dec 20232:00 pmRNSFundraise, Update on Future CLN Financing & TVR
16th Nov 20237:00 amRNSNew European Sales Contract
13th Oct 20237:00 amRNSFundraise, CLN Issue, Joint Broker Appointed & TVR
28th Sep 20237:00 amRNSInterim Results
18th Sep 20237:00 amRNSNotice of Results and Investor Presentation
5th Sep 20237:00 amRNSNew Sales Contract with UK Pharmaceutical Company
1st Aug 20237:00 amRNSApproval to roll-out chronic pain clinical trial
29th Jun 20235:30 pmRNSResult of AGM
5th Jun 20232:46 pmRNSPublication of Annual Report and Notice of AGM
5th Jun 20237:00 amRNSFinal Results for the year ended 31 December 2022
30th May 20237:00 amRNS£7 Million Committed Credit Facility
26th May 20237:00 amRNSNotice of Results and Investor Presentation
25th May 20237:00 amRNSWest Midlands Mayor Visits Celadon’s Facility
24th May 20237:00 amRNSInaugural Supply Contract Win
29th Mar 202311:05 amRNSSecond Price Monitoring Extn
29th Mar 202311:00 amRNSPrice Monitoring Extension
17th Mar 20234:35 pmRNSPrice Monitoring Extension
17th Mar 20232:05 pmRNSSecond Price Monitoring Extn
17th Mar 20232:00 pmRNSPrice Monitoring Extension
14th Mar 20233:01 pmRNSSuccessful Update to Home Office Licence
14th Mar 20232:05 pmRNSSecond Price Monitoring Extn
14th Mar 20232:00 pmRNSPrice Monitoring Extension
13th Mar 20234:40 pmRNSSecond Price Monitoring Extn
13th Mar 20234:35 pmRNSPrice Monitoring Extension
13th Mar 20239:05 amRNSSecond Price Monitoring Extn
13th Mar 20239:00 amRNSPrice Monitoring Extension
10th Mar 20234:40 pmRNSSecond Price Monitoring Extn
10th Mar 20234:35 pmRNSPrice Monitoring Extension
10th Mar 20232:05 pmRNSSecond Price Monitoring Extn
10th Mar 20232:00 pmRNSPrice Monitoring Extension
10th Feb 20232:15 pmRNSNotification of transaction by PDMR
19th Jan 20237:00 amRNSChange of Website Address
16th Jan 20237:00 amRNSApproval of GMP Registration by MHRA
13th Jan 20237:00 amRNSUpdate on CFO Appointment
30th Dec 20227:00 amRNSResults of Feasibility Study
22nd Dec 20227:00 amRNSUpdate on GMP Registration by MHRA
1st Nov 20227:00 amRNSAppointment of CFO
29th Sep 20227:00 amRNSInterim Report for six months ended 30 June 2022
12th Sep 20227:00 amRNSNotice of Results
28th Jul 20227:00 amRNSAppointment of Tessera Investment Management
27th Jun 20226:15 pmRNSResult of AGM
22nd Jun 20227:00 amRNSBusiness Update
31st May 20221:30 pmRNSNotice of AGM
29th Apr 20227:00 amRNSFull year results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.